These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2176673)
41. Detection of hepatitis A virus proteins in infected BS-C-1 cells. Updike WS; Tesar M; Ehrenfeld E Virology; 1991 Nov; 185(1):411-8. PubMed ID: 1656592 [TBL] [Abstract][Full Text] [Related]
42. Induction of neutralizing antibodies by type 1 poliovirus VP1 capsid polypeptide. Crainic R; Blondel B; Horaud F Dev Biol Stand; 1983; 55():185-9. PubMed ID: 6329856 [TBL] [Abstract][Full Text] [Related]
43. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge. Kim JY; Jeon ES; Lim BK; Kim SM; Chung SK; Kim JM; Park SI; Jo I; Nam JH Vaccine; 2005 Feb; 23(14):1672-9. PubMed ID: 15705471 [TBL] [Abstract][Full Text] [Related]
44. Induction of neutralizing antibodies by synthetic peptides representing the C terminus of coxsackievirus A9 capsid protein VP1. Pulli T; Roivainen M; Hovi T; Hyypiä T J Gen Virol; 1998 Sep; 79 ( Pt 9)():2249-53. PubMed ID: 9747735 [TBL] [Abstract][Full Text] [Related]
45. Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. Gahéry-Ségard H; Farace F; Godfrin D; Gaston J; Lengagne R; Tursz T; Boulanger P; Guillet JG J Virol; 1998 Mar; 72(3):2388-97. PubMed ID: 9499099 [TBL] [Abstract][Full Text] [Related]
46. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1. Rodríguez A; Sáiz JC; Novella IS; Andreu D; Sobrino F Virology; 1994 Nov; 205(1):24-33. PubMed ID: 7526534 [TBL] [Abstract][Full Text] [Related]
47. Characterization of a simian hepatitis A virus (HAV): antigenic and genetic comparison with human HAV. Brown EA; Jansen RW; Lemon SM J Virol; 1989 Nov; 63(11):4932-7. PubMed ID: 2552172 [TBL] [Abstract][Full Text] [Related]
48. Antigenic sites of coxsackievirus A9. Pulli T; Lankinen H; Roivainen M; Hyypiä T Virology; 1998 Jan; 240(2):202-12. PubMed ID: 9454693 [TBL] [Abstract][Full Text] [Related]
49. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Mayr GA; Chinsangaram J; Grubman MJ Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121 [TBL] [Abstract][Full Text] [Related]
50. [Synthesis and immunochemical properties of oligopeptides--fragments of capsid proteins of the hepatitis A virus]. Chikin LD; Kozhich AT; Ivanov VS; Ivanov VT; Nastashenko TA; Kusov IuIu; Balaian MS Bioorg Khim; 1991 Jul; 17(7):964-72. PubMed ID: 1724368 [TBL] [Abstract][Full Text] [Related]
51. [Mapping of the structural proteins of the hepatitis A virus]. Kusov IuIu; Kazachkov IuA; Dzagurov GK; Nastashenko TA; Balaian MS; Kozhich AT Vopr Virusol; 1990; 35(6):468-71. PubMed ID: 1964513 [TBL] [Abstract][Full Text] [Related]
52. Characterization of a hepatitis A virus strain suitable for vaccine production. Fineschi N; Cavalieri F; Garelick H; Prugnola A; Pellegrini V; Zuckerman AJ J Hepatol; 1991; 13 Suppl 4():S146-51. PubMed ID: 1668326 [TBL] [Abstract][Full Text] [Related]
53. Immunogenicity of enterovirus 70 capsid protein VP1 and its non-overlapping N- and C-terminal fragments. Chen D; Duggan C; Texada DE; Reden TB; Kooragayala LM; Langford MP Antiviral Res; 2005 Jun; 66(2-3):111-7. PubMed ID: 15911028 [TBL] [Abstract][Full Text] [Related]
54. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif. Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234 [TBL] [Abstract][Full Text] [Related]
55. Antigenic profile of African horse sickness virus serotype 4 VP5 and identification of a neutralizing epitope shared with bluetongue virus and epizootic hemorrhagic disease virus. Martínez-Torrecuadrada JL; Langeveld JP; Venteo A; Sanz A; Dalsgaard K; Hamilton WD; Meloen RH; Casal JI Virology; 1999 May; 257(2):449-59. PubMed ID: 10329555 [TBL] [Abstract][Full Text] [Related]
56. [Simultaneous detection of IgM antibodies against the hepatitis A virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis]. Naveau S; Delfraissy JF; Poitrine A; Poynard T; Chaput JC Gastroenterol Clin Biol; 1985 Feb; 9(2):109-12. PubMed ID: 2984075 [TBL] [Abstract][Full Text] [Related]
57. Four independent antigenic determinants on the capsid polypeptides of aphthovirus. Haresnape JM; McCahon D J Gen Virol; 1983 Nov; 64 (Pt 11)():2345-55. PubMed ID: 6196438 [TBL] [Abstract][Full Text] [Related]
58. Development and evaluation of a VP1-ELISA for detection of antibodies to duck hepatitis type 1 virus. Liu M; Zhang T; Zhang Y; Meng F; Li X; Hou Z; Feng X; Kong X J Virol Methods; 2010 Oct; 169(1):66-9. PubMed ID: 20609374 [TBL] [Abstract][Full Text] [Related]
59. Binding of neutralizing monoclonal antibodies to empty capsids of poliovirus can be blocked by monospecific antisera to structural polypeptides VP1 and VP2. Uhlig H; Haardt F; Dernick R Arch Virol; 1985; 83(3-4):295-303. PubMed ID: 2578787 [TBL] [Abstract][Full Text] [Related]